The emerging role of copper-64 radiopharmaceuticals as cancer theranostics
A Boschi, P Martini, E Janevik-Ivanovska, A Duatti - Drug Discovery Today, 2018 - Elsevier
Highlights•Copper radionuclides for in vivo imaging of biological functions of copper
ions.•Copper-64 has suitable nuclear properties for cancer theranostics.•Radioactive copper …
ions.•Copper-64 has suitable nuclear properties for cancer theranostics.•Radioactive copper …
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics
A Boschi, P Martini, E Janevik-Ivanovska… - Drug Discovery …, 2018 - eprints.ugd.edu.mk
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
[引用][C] The emerging role of copper-64 radiopharmaceuticals as cancer theranostics
A Boschi, P Martini, E Janevik-Ivanovska… - Drug Discovery …, 2018 - cir.nii.ac.jp
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF][PDF] The emerging role of copper-64 radiopharmaceuticals as cancer theranostics
A Boschi, P Martini, E Janevik-Ivanovska… - Drug Discovery …, 2018 - csmres.co.uk
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics.
A Boschi, P Martini, E Janevik-Ivanovska… - Drug Discovery …, 2018 - europepmc.org
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
[PDF][PDF] The emerging role of copper-64 radiopharmaceuticals as cancer theranostics
A Boschi, P Martini, E Janevik-Ivanovska, A Duatti - iris.unife.it
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics
A Boschi, P Martini… - Drug discovery …, 2018 - pubmed.ncbi.nlm.nih.gov
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in
oncology, particularly 64 Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
oncology, particularly 64 Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics
A Boschi, P Martini, E Janevik-Ivanovska… - Drug Discovery …, 2018 - eprints.ugd.edu.mk
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
[PDF][PDF] The emerging role of copper-64 radiopharmaceuticals as cancer theranostics
A Boschi, P Martini, E Janevik-Ivanovska, A Duatti - iris.unife.it
Copper radionuclides are rapidly emerging as potential diagnostic and therapeutic tools in
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …
oncology, particularly 64Cu-radiopharmaceuticals for targeting neuroendocrine, prostate …